You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
603 Phase II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): big ten cancer research consortium (BTCRC-LUN17–127) study

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023214011
Dec 20234906
Jan 20244803
Feb 20241801
Mar 20244002
Apr 20244001
May 20246402
Jun 20246602
Jul 20244207
Aug 20247400
Sep 20244302
Oct 20243602
Nov 20243608
Dec 20243807
Jan 20253205
Feb 2025202
Mar 2025005
Apr 2025003
May 2025007
Jun 2025107
Total843083